These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 955362)

  • 1. [Evidence for regression of carcinoma-in-situ and for a second form of invasive cervical cancer, Connecticut 1935-73].
    Meigs JW; Laskey PW; Flannery JT
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):554-69. PubMed ID: 955362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Registration of carcinoma in situ and squamous cell carcinoma of the uterine cervix in the screening area of Nijmegen from 1 January 1970 through 31 July 1982].
    Klinkhamer PJ; van der Graaf Y; Vooijs GP
    Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1979-83. PubMed ID: 6504185
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of the impact of screening for cancer of the cervix.
    Miller AB
    IARC Sci Publ; 1986; (76):149-60. PubMed ID: 3570400
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer screening programs. I. Epidemiology and natural history of carcinoma of the cervix.
    Can Med Assoc J; 1976 Jun; 114(11):1003-12. PubMed ID: 776378
    [No Abstract]   [Full Text] [Related]  

  • 5. Cervical cancer screening: précis and critique of a recent Canadian report.
    Chiavetta J; Leader SR
    Med J Aust; 1977 Jan 1-8; 1(1-2):23-8. PubMed ID: 840075
    [No Abstract]   [Full Text] [Related]  

  • 6. A cohort study of cervical cancer screening in British Columbia.
    Boyes DA; Morrison B; Knox EG; Draper GJ; Miller AB
    Clin Invest Med; 1982; 5(1):1-29. PubMed ID: 7116711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cervico-uterine cancer and age].
    Verduzca Rodríguez LA; Palet Guzmán JA; Aguirre González H; González Puebla E
    Ginecol Obstet Mex; 1997 Apr; 65():119-22. PubMed ID: 9280734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arkansas cervical cancer program.
    Steinkamp RC; Roman-Lopez J; Kenney JA; Hairston MG; Hylton S; Hammett WN; Marsh S; Becton P; Collier S
    J Ark Med Soc; 1980 Jan; 76(1):312-22. PubMed ID: 6444400
    [No Abstract]   [Full Text] [Related]  

  • 9. Cervical carcinoma in Frederiksberg borough: the influence of population screening on incidence and stage distribution of invasive cases.
    Gad C
    Dan Med Bull; 1976 May; 23(2):86-95. PubMed ID: 949913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the Leiden mass screening for cervix uteri carcinoma; the 'young' (24-34 years) versus the 'old' (35-54 years) group of women].
    Boon ME; de Graaff Guilloud-Gentenaar JC; Beck S
    Ned Tijdschr Geneeskd; 1990 Aug; 134(32):1545-9. PubMed ID: 2392176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 12. Uterine cervical carcinoma in Connecticut, 1935-1973: evidence for two classes of invasive disease.
    Laskey PW; Meigs JW; Flannery JT
    J Natl Cancer Inst; 1976 Nov; 57(5):1037-43. PubMed ID: 1003540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic characteristics in patients with epithelial dysplasi, carcinoma in situ, and invasive carcinoma of the uterine cervix. The population screening for cervical carcinoma in Maribo amt (county) 1967-1969.
    Berget A
    Dan Med Bull; 1975 Sep; 22(6):252-9. PubMed ID: 1175395
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of cytologic mass screening in the Federal Republic of Germany.
    Soost HJ; Bockmühl B; Zock H
    Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of cancer of the cervix uteri].
    Walton RJ; Blanchet M; Boyes DA; Carmichael J; Marshall KG; Miller AB; Thompson DW
    Union Med Can; 1976 Jul; 105(7):997-1047. PubMed ID: 960289
    [No Abstract]   [Full Text] [Related]  

  • 16. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries.
    Boice JD; Day NE; Andersen A; Brinton LA; Brown R; Choi NW; Clarke EA; Coleman MP; Curtis RE; Flannery JT
    J Natl Cancer Inst; 1985 May; 74(5):955-75. PubMed ID: 3858584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes of morbidity and mortality from cancer of the cervix uteri in Puerto Rico.
    Martínez I
    Bol Asoc Med P R; 1984 Mar; 76(3):100-6. PubMed ID: 6586182
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of the age factor in dysplasia and preinvasive and invasive cancer of the cervix uteri in the Parma area].
    Spreafichi F; Gramellini D; Sppreafico L
    Ann Ostet Ginecol Med Perinat; 1976; 97(6):389-97. PubMed ID: 1015753
    [No Abstract]   [Full Text] [Related]  

  • 20. 1991 cervical screening recommendations: a working group report.
    Paul C; Bagshaw S; Bonita R; Durham G; Fitzgerald NW; Jones RW; Marshall B; McAvoy BR
    N Z Med J; 1991 Jul; 104(915):291-5. PubMed ID: 1906587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.